You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 2076 to 2100 of about 5897
Next 25
05/05/2014
Aduro BioTech Announces Initation of a Clinical Trial of Its Novel Immunotherapy in Patients with Brain Cancer at Providence Cancer Center
05/04/2014
Human fat can help treat brain cancer
05/03/2014
Breast Cancer, Brain Tumors Not Caused by Viruses
05/02/2014
Why is glioblastoma so deadly? DelMar discusses the need for new cancer research and treatments for Brain Tumor Awareness Month
05/01/2014
BMX Fundraiser May 9, Dayton, Oh
Clinical Trials Survey
04/29/2014
Local families aim to reach the finish line for brain cancer
Cetuximab plus chemotherapy yielded worse outcomes in metastatic colorectal cancer
Patient and Caregiver Brain Tumor Support Symposium
04/27/2014
Aquaporin-4 in glioma and metastatic tissues harboring 5-aminolevulinic acid-induced porphyrin fluorescence.
04/26/2014
Apoptosis Therapy in Cancer: The First Single-molecule Co-activating p53 and the Translocator Protein in Glioblastoma.
04/23/2014
Call For Brain Tumor Research Grant Proposals
Glioblastoma stem cells: a new target for metformin and arsenic trioxide.
Glioblastoma Vaccine Hits Primary Endpoints in Phase 1
04/18/2014
A phase 2 trial of verubulin for recurrent glioblastoma: a prospective study by the brain tumor investigational consortium (BTIC).
UCLA 14th Annual Brain Tumor Conference
Battling Cancer Mind Over Body
Stereotactic biopsy of brainstem lesions: Techniques, efficacy, safety, and disease variation between adults and children: A single institutional series and review.
"Brain Tumor Forum" patient conference
04/16/2014
ERGO: A pilot study of ketogenic diet in recurrent glioblastoma.
Additive homeopathy in cancer patients: Retrospective survival data from a homeopathic outpatient unit at the Medical University of Vienna.
New Clinical Trials Finder on Virtualtrials.com
04/13/2014
Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared to temozolomide-chemoradiation for unresectable glioblastoma. Final results of the TEMAVIR study from ANOCEF.
04/12/2014
Interim Clinical Data for Tocagen`s Toca 511 & Toca FC in Patients with High Grade Glioma
Influenza vaccine immunogenicity in patients with primary central nervous system malignancy.